Vertex Clinical Sciences is a full-service contract research organization specializing in oncology and rare disease clinical trials. The company operates across 28 countries with decentralized trial capabilities, adaptive trial design expertise, and an integrated bioanalytical platform.
Vertex Clinical Sciences was founded in 2018 by a team of clinical operations veterans from IQVIA and Medpace with a mission to build a CRO purpose-built for complex therapeutic areas. The company has grown rapidly, establishing a global footprint across North America, Europe, and Asia-Pacific with particular depth in oncology biomarker-driven trials and rare disease programs requiring adaptive designs.
The company's integrated platform combines site management, electronic data capture, central lab services, and real-time analytics into a single operational layer. This approach has reduced median database lock times by 35% compared to industry averages and earned Vertex recognition as a top emerging CRO by Clinical Leader magazine in 2024 and 2025.
Vertex operates an in-house bioanalytical lab in Cambridge, MA, with CLIA certification and CAP accreditation, supporting PK/PD, immunogenicity, and companion diagnostic sample analysis. Their decentralized trial division launched in 2022 and now supports hybrid protocols in 14 countries with in-home nursing, eConsent, and direct-to-patient drug shipment.
Embedded company video or media presentation
This dedicated landing page is permanently hosted and SEO-indexed on biomednexus.com, a high-authority biotech domain. It ranks for search terms related to your company name and service categories, driving organic referral traffic year-round. The page is linked from your featured directory listing, editorial coverage, and newsletter mentions.
BioMed Nexus reaches 86,757 newsletter subscribers, generates 1.4M monthly impressions, and drives 30,000+ weekly website visitors across 56,023 corporate domains including Pfizer, Novartis, Merck, AstraZeneca, J&J, Roche, and Gilead.
This is a Data Partner landing page on BioMed Nexus. Learn more about the Data Partner program →
